The mechanism and influencing factors of missed diagnosis risk in new gastric cancer screening scoring systems for low-risk populations: A review
By: Pengfei Shao, Yurong Xie, Yibi Ranhen, Ci Yang, Basang Zhuoma and Wei Li
References
- Li D, Morgan DR, Corral JE, Montgomery EA, Riquelme A, Shah SC. Gastric cancer screening in the united states: A review of current evidence, challenges, and future perspectives. Am J Gastroenterol. 2025; 120(4): 765–777.
- Abengozar R, Sharma A, Sharma R. Gastric cancer: Lessons learned from high-incidence geographic regions. J Gastrointest Oncol. 2021; 12(Suppl. 2): S350–S360.
- Leung WK, Ang TL, Shah S, Cheung KS, Li Y, Uedo N, Li WQ, Yeoh KG, Vilaichone RK, Lui TK, et al. Asian pacific association of gastroenterology task force recommendations on surveillance for helicobacter pylori associated gastric premalignant conditions. Gut. 2026 Mar 6;75(4):685–704.
- Niu C, Song Y, Chen Y, Shi Y, Wang H, Wu X, Wang X, Zhao X, Bu Y, Li J, et al. Epidemiology of Helicobacter pylori, gastric precancerous lesions and gastric cancer: A multicenter, population-based cross-sectional study in Nanjing. BMC Infect Dis. 2025; 25(1): 766.
- Kang K, Bagaoisan MA, Zhang Y. Unveiling the younger face of gastric cancer: A comprehensive review of epidemiology, risk factors, and prevention strategies. Cureus. 2024; 16(6): e62826.
- Petryszyn P, Chapelle N, Matysiak-Budnik T. Gastric cancer: Where are we heading? Dig Dis. 2020; 38(4): 280–285.
- Mabe K, Inoue K, Kamada T, Kato K, Kato M, Haruma K. Endoscopic screening for gastric cancer in Japan: Current status and future perspectives. Dig Endosc. 2022; 34(3): 412–419.
- Kim YI. Performance of the national cancer screening program for gastric cancer in Korea. Korean J Helicobacter Up Gastrointest Res. 2024; 24(3): 231–237.
- Kishino T, Oyama T, Tomori A, Takahashi A, Shinohara T. Usefulness and limitations of a serum screening system to predict the risk of gastric cancer. Intern Med. 2020; 59(12): 1473–1480.
- Zhou Q, Chen Y, Pan J, Zhou L, Lin J. Application of a novel scoring system for gastric cancer opportunistic screening in hospital visits. BMC Gastroenterol. 2022; 22(1): 223.
- Wang X, Zhang Q, Han F, Wu Y. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China. Scand J Gastroenterol. 2023; 58(1): 34–37.
- Zhou R, Zheng H, Liu M, Liu Z, Guo C, Tian H, Liu F, Liu Y, Pan Y, Chen H, et al. Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations. Chin J Cancer Res. 2021; 33(6): 649–658.
- Li L, Ni J, Sun S, Zha X, Li R, He C. Clinical applicability of a new scoring system for population-based screening and risk factors of gastric cancer in the Wannan region. BMC Gastroenterol. 2022; 22(1): 306.
- Kawamura M, Uedo N, Koike T, Kanesaka T, Hatta W, Ogata Y, Oikawa T, Iwai W, Yokosawa S, Honda J, et al. Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan. Dig Endosc. 2022; 34(3): 508–516.
- Ding P, Lv J, Sun C, Chen S, Yang P, Tian Y, Zhou Q, Guo H, Liu Y, Zhao Q. Combined systemic inflammatory immunity index and prognostic nutritional index scores as a screening marker for sarcopenia in patients with locally advanced gastric cancer. Front Nutr. 2022; 9: 981533.
- Wang JB, Li P, Liu XL, Zheng QL, Ma YB, Zhao YJ, Xie JW, Lin JX, Lu J, Chen QY, et al. An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer. Nat Commun. 2020; 11(1): 6352.
- Zhao W, Li T, Wang P, Zhang R, Gao F, Ma Z, Zhen S, Liu F, Chu Y. Development and validation of a relatively accurate gastric cancer high-risk group screening scoring system in urban residents. Clin Transl Oncol. 2025; 27(5): 2269–2280.
- Feng HH, Zhang WH, Liu K, Chen XL, Zhao LY, Chen XZ, Yang K, Hu JK. Prognostic value of a serological-based clinical model for gastric cancer patients. J Clin Med. 2025; 14(12): 4043.
- Wang X, Zhang L. The systemic oxidative stress score has a prognostic value on gastric cancer patients undergoing surgery. Front Oncol. 2024; 14: 1307662.
- Zheng P, Liu J. Cost-effectiveness analysis of hp and new gastric cancer screening scoring system for screening and prevention of gastric cancer. Curr Oncol. 2023; 30(1): 1132–1145.
- Wang XT, Ji ZZ, Han F, Lyu B. A comparative study of new gastric cancer screening scoring system and new ABC method for screening gastric cancer and precancerous lesions. Zhonghua Nei Ke Za Zhi. 2021; 60(3): 227–232.
- Waddingham W, Nieuwenburg SAV, Carlson S, Rodriguez-Justo M, Spaander M, Kuipers EJ, Jansen M, Graham DG, Banks M. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterol. 2021; 12(4): 322–331.
- He S, Zhang Z, Song G, Wang Z, Li H, Cao M, Yang F, Sun D, Yan X, Zhang S, et al. Personalized starting age of gastric cancer screening based on individuals’ risk profiles: A population-based, prospective study. J Natl Cancer Inst. 2024; 116(11): 1775–1783.
- Maruta LM, Furukawa A, Seidler HBK, Felipe-Silva A, Uchida K, Kobayashi D, Yamamoto K, Minami J, Sekine M, Takagi M, et al. Validation of the ABC method for gastric cancer risk stratification across helicobacter pylori infections with diverse CagA status and subtypes in Brazil. Cancer Med. 2025; 14(13): e71016.
- Tjandra D, Busuttil RA, Boussioutas A. Gastric intestinal metaplasia: Challenges and the opportunity for precision prevention. Cancers (Basel). 2023; 15(15): 3913.
- Shah SC, Wang AY, Wallace MB, Hwang JH. AGA clinical practice update on screening and surveillance in individuals at increased risk for gastric cancer in the United States: Expert review. Gastroenterology. 2025; 168(2): 405–416.e401.
- Stryelkina M, Nguyen M, Reddy P, Doan AT, Min M, Go L, Wong L. Early onset gastric cancer: Clinical and molecular insights into a rising epidemic among younger adults. Proc (Bayl Univ Med Cent). 2025; 38(4): 388–396.
- Deng W, Hao Q, Vadgama J, Wu Y. Wild-type TP53 predicts poor prognosis in patients with gastric cancer. J Cancer Sci Clin Ther. 2021; 5(1): 134–153.
- Yao L, Sun YM, Liu MF, Xiang JN, Wang S, Man CF, He R, Yu J, Fan Y. Integrating single-cell transcriptomic data of metastatic gastric cancer to construct a tumor-associated neutrophil signature and clinical validation in MSS/pMMR patients. ACS Omega. 2025; 10(38): 44558–44572.
- Zeng C, He R, Dai Y, Lu X, Deng L, Zhu Q, Liu Y, Liu Q, Lu W, Wang Y, et al. Identification of TGF-beta signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer. Front Pharmacol. 2022; 13: 1069204.
- Zhu M, Cai J, Wu Y, Wu X, Feng L, Yin Z. A novel RNA-binding protein-based nomogram for predicting survival of patients with gastric cancer. Med Sci Monit. 2021; 27: e928195.
- He F, Ding H, Zhou Y, Wang Y, Xie J, Yang S, Zhu Y. Depiction of aging-based molecular phenotypes with diverse clinical prognosis and immunological features in gastric cancer. Front Med (Lausanne). 2021; 8: 792740.
- Allen CJ, Blumenthaler AN, Das P, Minsky BD, Blum M, Roy-Chowdhuri S, Ajani JA, Ikoma N, Mansfield PF, Badgwell BD. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma. World J Surg Oncol. 2020; 18(1): 39.
- Ma D, Zhang Y, Shao X, Wu C, Wu J. PET/CT for predicting occult lymph node metastasis in gastric cancer. Curr Oncol. 2022; 29(9): 6523–6539.
- Shioya A, Kurose N, Mizutani K, Kumagai M, Kawaura K, Nakamura N, Kosaka T, Motono N, Uramoto H, Yamada S. Early-stage multi-differentiated gastric carcinosarcoma and post-resection local recurrence: A case report. Diagn Pathol. 2020; 15(1): 118.
- Liu F, Pan K, Zhang X, Zhang Y, Zhang L, Ma J, Dong C, Shen L, Li J, Deng D, et al. Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology. 2006; 130(7): 1975–1984.
- Ji XK, Madhurapantula SV, He G, Wang KY, Song CH, Zhang JY, Wang KJ. Genetic variant of cyclooxygenase-2 in gastric cancer: More inflammation and susceptibility. World J Gastroenterol. 2021; 27(28): 4653–4666.
- Song M, Rabkin CS, Ito H, Oze I, Koyanagi YN, Pfeiffer RM, Kasugai Y, Matsuo K, Camargo MC. Circulating immune- and inflammation-related biomarkers and early-stage noncardia gastric cancer risk. Eur J Cancer Prev. 2022; 31(3): 270–273.
- Karlsson K, Przybilla MJ, Kotler E, Khan A, Xu H, Karagyozova K, Sockell A, Wong WH, Liu K, Mah A, et al. Deterministic evolution and stringent selection during preneoplasia. Nature. 2023; 618(7964): 383–393.
- In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, Epplein M. Serum pepsinogen as a biomarker for gastric cancer in the United States: A nested case-control study using the PLCO cancer screening trial data. Cancer Epidemiol Biomarkers Prev. 2022; 31(7): 1426–1432.
- Coelho MCF, Ribeiro HG, Gomes CGO, Marinho FP, Barbosa AJA, Coelho LGV. Helicobacter pylori chronic gastritis on patients with premalignant conditions: Olga and olgim evaluation and serum biomarkers performance. Arq Gastroenterol. 2021; 58(1): 39–47.
- Guo P, Zhou XJ, Xu L, Chen H, Zhao L, Sun MH, Hu H. Application of fecal DNA methylation biomarkers detection in gastric cancer screening. Zhonghua Yi Xue Za Zhi. 2021; 101(11): 808–812.
- Nakane K, Yagi K, Yajima S, Nomura S, Sugimoto M, Seto Y. Salivary metabolomic biomarkers for esophageal and gastric cancers by liquid chromatography-mass spectrometry. Cancer Sci. 2024; 115(9): 3089–3098.
- Luan L, Yang L, Zhang Y, Liu J, Hu B, Ye L, Ye W, Shen J, Chen H, Qu X, et al. Highly sensitive multiplexed sensing of miRNAs in a gastric cancer patient’s liquid biopsy. Anal Chem. 2024; 96(50): 20015–20025.
- Huang HY, Lan J, Zhuang W. Role of circulating tumor DNA methylation in gastric cancer initiation and progression: A comprehensive review. World J Gastrointest Oncol. 2025; 17(8): 107412.
- Herrera-Pariente C, Montori S, Llach J, Bofill A, Albeniz E, Moreira L. Biomarkers for gastric cancer screening and early diagnosis. Biomedicines. 2021; 9(10): 1448.
- Cao QX, Yan L, Hou NY, Chen JF, Yu S, Lu HJ, Dan ZJ, Pang MH. Progress of circulating tumor DNA methylation for gastric cancer screening and management. Zhonghua Wei Chang Wai Ke Za Zhi. 2024; 27(5): 535–544.
- Santos JP, Figueiredo J, Machado JC. Gastric cancer genetics and its implications for diagnosis, prognosis, and treatment of the disease. Korean J Helicobacter Up Gastrointest Res. 2024; 24(2): 103–112.
- Kim MK, Rouphael C, Wehbe S, Yoon JY, Wisnivesky J, McMichael J, Welch N, Dasarathy S, Zabor EC. Using the electronic health record to develop a gastric cancer risk prediction model. Gastro Hep Adv. 2024; 3(7): 910–916.
- Xu L, Lyu J, Zheng X, Wang A. Risk prediction models for gastric cancer: A scoping review. J Multidiscip Healthc. 2024; 17: 4337–4352.
- Lee E, Jung SY, Hwang HJ, Jung J. Patient-level cancer prediction models from a nationwide patient cohort: Model development and validation. JMIR Med Inform. 2021; 9(8): e29807.
- Yu R, Sun T, Zhang X, Li Z, Xu Y, Liu K, Shi Y, Wu X, Shao Y, Kong L. TP53 Co-mutational features and NGS-calibrated immunohistochemistry threshold in gastric cancer. Onco Targets Ther. 2021; 14: 4967–4978.
- Qin S, Wang X, Li S, Wu M, Wan X. Personalizing age of gastric cancer screening based on comorbidity in China: Model estimates of benefits, affordability and cost-effectiveness optimization. Prev Med. 2024; 179: 107851.
- Miyaoka M, Yao K, Tanabe H, Kanemitsu T, Otsu K, Imamura K, Ono Y, Ishikawa S, Yasaka T, Ueki T, et al. Diagnosis of early gastric cancer using image enhanced endoscopy: A systematic approach. Transl Gastroenterol Hepatol. 2020; 5: 50.
- Lazar DC, Avram MF, Faur AC, Romosan I, Goldis A. The role of computer-assisted systems for upper-endoscopy quality monitoring and assessment of gastric lesions. Gastroenterol Rep (Oxf). 2021; 9(3): 185–204.
- Matsumoto K, Ueyama H, Yao T, Abe D, Oki S, Suzuki N, Ikeda A, Yatagai N, Akazawa Y, Komori H, et al. Diagnostic limitations of magnifying endoscopy with narrow-band imaging in early gastric cancer. Endosc Int Open. 2020; 8(10): E1233–E1242.
- Liang P, Lv D, Ren XC, Cheng M, Hu ZW, Yong LL, Zhu BB, Liu MR, Gao JB. The ‘double‑track sign’: A novel CT finding suggestive of the diagnosis of T1a gastric cancer. Oncol Lett. 2023; 26(1): 286.
- Fu J, Tang L, Li ZY, Li XT, Zhu HF, Sun YS, Ji JF. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy. Eur J Radiol. 2020; 128: 108974.
- Wang Z, Li W, Jin D, Fan B. Radiomics in the diagnosis of gastric cancer: Current status and future perspectives. Curr Med Imaging. 2023. PMID: 37881084.
- Xia S, Xia Y, Liu T, Luo Y, Pang PC. Application of deep learning models in gastric cancer pathology image analysis: A systematic scoping review. BMC Cancer. 2025; 25(1): 1257.
- Tan MC, Mallepally N, Nguyen TH, Hammad T, Kim DK, Othman MO, El-Serag HB, Thrift AP. Missed opportunities for screening or surveillance among patients with newly diagnosed non-cardia gastric adenocarcinoma. Dig Dis Sci. 2023; 68(3): 761–769.
- Wan J, Fang Y, Jiang H, Wang B, Xu L, Hu C, Chen H, Ding X. Endoscopic screening for missed lesions of synchronous multiple early gastric cancer during endoscopic submucosal dissection. Gastroenterol Res Pract. 2023; 2023: 2824573.
- Kim SJ, Choi CW. Common locations of gastric cancer: Review of research from the endoscopic submucosal dissection era. J Korean Med Sci. 2019; 34(35): e231.
- Li Y, Zhu S, Liu Y, He D, Liu Y, Li H. Economic evaluation of preventing gastric cancer by eliminating Helicobacter pylori infection in China. Scand J Gastroenterol. 2025; 60(4): 327–335.
- Kim DJ, Yoon NH, Kim S, Hwang HA, Jun JK, Suh M, Lee S, Lee SY, Lee H. Long-term adherence to gastric cancer screening in South Korea: A 10-year follow-up study. Chin J Cancer Res. 2025; 37(4): 592–602.
- Xia R, Zeng H, Liu W, Xie L, Shen M, Li P, Li H, Wei W, Chen W, Zhuang G. Estimated cost-effectiveness of endoscopic screening for upper gastrointestinal tract cancer in high-risk areas in China. JAMA Netw Open. 2021; 4(8): e2121403.
- Zacharakis G, Almasoud A, Arahmane O, Alzahrani J, Al-Ghamdi S. Epidemiology, risk factors for gastric cancer and surveillance of premalignant gastric lesions: A prospective cohort study of central Saudi Arabia. Curr Oncol. 2023; 30(9): 8338–8351.
- He X, Qi W, Wang Q, Zhao S. Knowledge and practice of early gastric cancer screening among adults aged >/= 45 years in China: A cross-sectional study. BMC Public Health. 2024; 24(1): 3099.
- Wu BU, Dong EY, Chen Q, Luong TQ, Lustigova E, Jeon CY, Chen W. Stomach cancer prediction model (SCoPM): An approach to risk stratification in a diverse U.S. population. PLoS One. 2024; 19(5): e0303153.
- Ishibashi F, Okusa K. Cost-effective endoscopic screening strategies for asymptomatic gastric cancer. Digestion. 2025; 106(6): 616–623.
- Alsadoun L, Ul Hassan H, Kalansuriya I, Bai R, Raut Y, Jameel H, Rehman A, Kadri F, Anika NN, Khattak AU, et al. Genetic markers of susceptibility in gastric cancer: A comprehensive systematic review. Cureus. 2024; 16(9): e68358.
- Kim IH, Kang SJ, Choi W, Seo AN, Eom BW, Kang B, Kim BJ, Min BH, Tae CH, Choi CI, et al. Korean practice guidelines for gastric cancer 2024: An evidence-based, multidisciplinary approach (update of 2022 guideline). J Gastric Cancer. 2025; 25(1): 5–114.
- Hsiao YJ, Wen YC, Lai WY, Lin YY, Yang YP, Chien Y, Yarmishyn AA, Hwang DK, Lin TC, Chang YC, et al. Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer. World J Gastroenterol. 2021; 27(22): 2979–2993.
- Fu XY, Mao XL, Chen YH, You NN, Song YQ, Zhang LH, Cai Y, Ye XN, Ye LP, Li SW. The feasibility of applying artificial intelligence to gastrointestinal endoscopy to improve the detection rate of early gastric cancer screening. Front Med (Lausanne). 2022; 9: 886853.
- Oura H, Matsumura T, Fujie M, Ishikawa T, Nagashima A, Shiratori W, Tokunaga M, Kaneko T, Imai Y, Oike T, et al. Development and evaluation of a double-check support system using artificial intelligence in endoscopic screening for gastric cancer. Gastric Cancer. 2022; 25(2): 392–400.
- Gao Y, Wen P, Liu Y, Sun Y, Qian H, Zhang X, Peng H, Gao Y, Li C, Gu Z, et al. Application of artificial intelligence in the diagnosis of malignant digestive tract tumors: Focusing on opportunities and challenges in endoscopy and pathology. J Transl Med. 2025; 23(1): 412.
- Zhang R, Liu Z, Zhu C, Cai H, Yin K, Zhong F, Liu L. Constructing a clinical patient similarity network of gastric cancer. Bioengineering (Basel). 2024; 11(8): 808.
- Patel SK, George B, Rai V. Artificial intelligence to decode cancer mechanism: Beyond patient stratification for precision oncology. Front Pharmacol. 2020; 11: 1177.
- Wang L, Zhang Q, Zhang P, Wu B, Chen J, Gong J, Tang K, Du S, Li S. Development of an artificial intelligent model for pre-endoscopic screening of precancerous lesions in gastric cancer. Chin Med. 2024; 19(1): 90.
- Deshmukh R, Verma S, Yaduwanshi PS, Dubey A, Kumari M. Molecular-targeted therapy for precision medicine in gastrointestinal cancer: Advancement in cancer targeting strategies. Curr Cancer Drug Targets. 2025; 25(7): 715–735.
- Huang Y, Shao Y, Yu X, Chen C, Guo J, Ye G. Global progress and future prospects of early gastric cancer screening. J Cancer. 2024; 15(10): 3045–3064.
- Haddad G, Schouwenburg S, Altesha A, Xu W, Liu G. Using breath analysis as a screening tool to detect gastric cancer: A systematic review. J Breath Res. 2020; 15(1): 01601.
- Zhang J, Tian Y, Luo Z, Qian C, Li W, Duan Y. Breath volatile organic compound analysis: An emerging method for gastric cancer detection. J Breath Res. 2021; 15(4): 044002.
- Li M, He H, Huang G, Lin B, Tian H, Xia K, Yuan C, Zhan X, Zhang Y, Fu W. A novel and rapid serum detection technology for non-invasive screening of gastric cancer based on raman spectroscopy combined with different machine learning methods. Front Oncol. 2021; 11: 665176.
- Huang X, Qin M, Fang M, Wang Z, Hu C, Zhao T, Qin Z, Zhu H, Wu L, Yu G, et al. The application of artificial intelligence in upper gastrointestinal cancers. J Natl Cancer Cent. 2025; 5(2): 113–131.
- Chen ZL, Wang C, Wang F. Revolutionizing gastroenterology and hepatology with artificial intelligence: From precision diagnosis to equitable healthcare through interdisciplinary practice. World J Gastroenterol. 2025; 31(24): 108021.
- Li JH, Zhang DY, Zhu JM, Dong L. Clinical applications and perspectives of circulating tumor DNA in gastric cancer. Cancer Cell Int. 2024; 24(1): 13.
- Han Y, Zhang P, Gong Y, Song L. Development and clinical applications of liquid biopsy assays in cancer screening. Transl Cancer Res. 2025; 14(6): 3846–3859.
DOI: https://doi.org/10.2478/ahem-2026-0005 | Journal eISSN: 1732-2693
Language: English
Page range: 39 - 60
Submitted on: Dec 17, 2025
Accepted on: Mar 12, 2026
Published on: Apr 1, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2026 Pengfei Shao, Yurong Xie, Yibi Ranhen, Ci Yang, Basang Zhuoma, Wei Li, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.